Causal associations between blood metabolites and breast cancer

Introduction The associations between blood metabolites and breast cancer remain unclear. We conducted a systematic two-sample Mendelian randomization (MR) analysis to identify key human blood metabolites and potential biomarkers for breast cancer development. Material and methods The data were ext...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanying Liang, Dazhuang Miao, Chun Du
Format: Article
Language:English
Published: Termedia Publishing House 2024-06-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/Causal-associations-between-blood-metabolites-and-breast-cancer,188275,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850275706322288640
author Guanying Liang
Dazhuang Miao
Chun Du
author_facet Guanying Liang
Dazhuang Miao
Chun Du
author_sort Guanying Liang
collection DOAJ
description Introduction The associations between blood metabolites and breast cancer remain unclear. We conducted a systematic two-sample Mendelian randomization (MR) analysis to identify key human blood metabolites and potential biomarkers for breast cancer development. Material and methods The data were extracted from large-scale genome-wide association study (GWAS) public databases. Instrumental variables were selected from a cohort study of 453 metabolic profiles from 7,824 participants. Breast cancer incidence data were obtained from a large cohort study involving 138,389 cases and 240,341 controls. Causal associations between human blood metabolites and breast cancer incidence were assessed using inverse-variance weighting, and MR-Egger regression. Results Five human blood metabolites were identified as biomarkers for breast cancer: serine (OR = 2.25; 95% CI: 1.18–4.27), 10-undecenoate (11:1n1) (OR = 1.38; 95% CI: 1.00–1.90), X-12696 (OR = 2.15; 95% CI: 1.14–4.08), X-14626 (OR = 1.68; 95% CI: 1.15–2.46), and succinyl carnitine (OR = 1.58; 95% CI: 1.06–2.34). The sensitivity analysis results indicate no pleiotropy between the metabolites and breast cancer risk, confirming the robustness of the findings. Conclusions This study in metabolomics research identified five human blood metabolites – serine, 10-undecenoate (11:1n1), X-12696, X-14626, and succinylcarnitine – as potential biomarkers for assessing breast cancer risk. Among these metabolites, serine and X-12696 showed the strongest associations with the likelihood of developing breast cancer.
format Article
id doaj-art-e4a30f464513430eb61ccd5dbe406320
institution OA Journals
issn 1734-1922
1896-9151
language English
publishDate 2024-06-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj-art-e4a30f464513430eb61ccd5dbe4063202025-08-20T01:50:38ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512024-06-0121120621410.5114/aoms/188275188275Causal associations between blood metabolites and breast cancerGuanying Liang0Dazhuang Miao1Chun Du2Department of Pathology, Affiliated Cancer Hospital of Harbin Medical University, Nangang, Harbin, Heilongjiang, ChinaDepartment of Colorectal Cancer Surgery, Affiliated Cancer Hospital of Harbin Medical University, Nangang, Harbin, Heilongjiang, ChinaDepartment of Pathology, Affiliated Cancer Hospital of Harbin Medical University, Nangang, Harbin, Heilongjiang, ChinaIntroduction The associations between blood metabolites and breast cancer remain unclear. We conducted a systematic two-sample Mendelian randomization (MR) analysis to identify key human blood metabolites and potential biomarkers for breast cancer development. Material and methods The data were extracted from large-scale genome-wide association study (GWAS) public databases. Instrumental variables were selected from a cohort study of 453 metabolic profiles from 7,824 participants. Breast cancer incidence data were obtained from a large cohort study involving 138,389 cases and 240,341 controls. Causal associations between human blood metabolites and breast cancer incidence were assessed using inverse-variance weighting, and MR-Egger regression. Results Five human blood metabolites were identified as biomarkers for breast cancer: serine (OR = 2.25; 95% CI: 1.18–4.27), 10-undecenoate (11:1n1) (OR = 1.38; 95% CI: 1.00–1.90), X-12696 (OR = 2.15; 95% CI: 1.14–4.08), X-14626 (OR = 1.68; 95% CI: 1.15–2.46), and succinyl carnitine (OR = 1.58; 95% CI: 1.06–2.34). The sensitivity analysis results indicate no pleiotropy between the metabolites and breast cancer risk, confirming the robustness of the findings. Conclusions This study in metabolomics research identified five human blood metabolites – serine, 10-undecenoate (11:1n1), X-12696, X-14626, and succinylcarnitine – as potential biomarkers for assessing breast cancer risk. Among these metabolites, serine and X-12696 showed the strongest associations with the likelihood of developing breast cancer.https://www.archivesofmedicalscience.com/Causal-associations-between-blood-metabolites-and-breast-cancer,188275,0,2.htmlmetabolitesbreast cancermendelian randomization
spellingShingle Guanying Liang
Dazhuang Miao
Chun Du
Causal associations between blood metabolites and breast cancer
Archives of Medical Science
metabolites
breast cancer
mendelian randomization
title Causal associations between blood metabolites and breast cancer
title_full Causal associations between blood metabolites and breast cancer
title_fullStr Causal associations between blood metabolites and breast cancer
title_full_unstemmed Causal associations between blood metabolites and breast cancer
title_short Causal associations between blood metabolites and breast cancer
title_sort causal associations between blood metabolites and breast cancer
topic metabolites
breast cancer
mendelian randomization
url https://www.archivesofmedicalscience.com/Causal-associations-between-blood-metabolites-and-breast-cancer,188275,0,2.html
work_keys_str_mv AT guanyingliang causalassociationsbetweenbloodmetabolitesandbreastcancer
AT dazhuangmiao causalassociationsbetweenbloodmetabolitesandbreastcancer
AT chundu causalassociationsbetweenbloodmetabolitesandbreastcancer